Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
You Zhou, Matej Orešič, Marja Leivonen, et al.
Clinical Gastroenterology and Hepatology (2016) Vol. 14, Iss. 10, pp. 1463-1472.e6
Open Access | Times Cited: 136

Showing 26-50 of 136 citing articles:

Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 45
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
Gabriele Mocciaro, Michael Allison, Benjamin Jenkins, et al.
Molecular Metabolism (2023) Vol. 73, pp. 101728-101728
Open Access | Times Cited: 27
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
Giovanni Musso, Francesca Saba, Maurizio Cassader, et al.
Progress in Lipid Research (2023) Vol. 91, pp. 101238-101238
Closed Access | Times Cited: 26
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
Maja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1248-1260
Open Access | Times Cited: 24
Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women
Ping Wu, Yi Wang, Yi Ye, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
Anastasiia Driuchina, Jukka Hintikka, Marko Lehtonen, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD
Alia Ghrayeb, Alexandra C Finney, Bella Agranovich, et al.
Cell Metabolism (2024) Vol. 36, Iss. 1, pp. 116-129.e7
Closed Access | Times Cited: 12
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
Carlos J. Pirola, Silvia Sookoian
World Journal of Gastroenterology (2018) Vol. 24, Iss. 15, pp. 1601-1615
Open Access | Times Cited: 70
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68
Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease
Cyrielle Caussy, Veeral Ajmera, Prem Puri, et al.
Gut (2018) Vol. 68, Iss. 10, pp. 1884-1892
Open Access | Times Cited: 65
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics
Silvia Sookoian, Carlos J. Pirola
Seminars in Liver Disease (2019) Vol. 39, Iss. 02, pp. 124-140
Open Access | Times Cited: 64
Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult
Jayanta Paul
Egyptian Liver Journal (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 55
Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis
Sara Guerra, Gabriele Mocciaro, Amalia Gastaldelli
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Closed Access | Times Cited: 44
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40
MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29
Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury
Hyo Won Lee, In-Jeong Lee, Soojin Lee, et al.
ACS Sensors (2022) Vol. 7, Iss. 4, pp. 1027-1035
Closed Access | Times Cited: 28
A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease
Qingxia Huang, S. U. Qadri, Hua Bian, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 5
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
Wonbeak Yoo, Donjeta Gjuka, Heather L. Stevenson, et al.
PLoS ONE (2017) Vol. 12, Iss. 12, pp. e0189965-e0189965
Open Access | Times Cited: 51
Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease
Bo Kyung Koo, Sae Kyung Joo, Donghee Kim, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 18, Iss. 11, pp. 2592-2599.e10
Open Access | Times Cited: 39
Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review
Cristina Piras, Antonio Noto, Luciano Ibba, et al.
Metabolites (2021) Vol. 11, Iss. 10, pp. 694-694
Open Access | Times Cited: 34
US Quantification of Liver Fat: Past, Present, and Future
David T. Fetzer, Theodore T. Pierce, Michelle L. Robbin, et al.
Radiographics (2023) Vol. 43, Iss. 7
Closed Access | Times Cited: 13
Bioactive signalling lipids as drivers of chronic liver diseases
Eleanna Kaffe, Annamaria Tisi, Christiana Magkrioti, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 140-154
Open Access | Times Cited: 12
Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5965-5965
Open Access | Times Cited: 4
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
Umberto Vespasiani‐Gentilucci, Paolo Gallo, Chiara Dell’Unto, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 43, pp. 4835-4845
Open Access | Times Cited: 41

Scroll to top